Ignite Creation Date:
2025-12-24 @ 1:41 PM
Ignite Modification Date:
2025-12-27 @ 9:11 PM
Study NCT ID:
NCT00130195
Status:
COMPLETED
Last Update Posted:
2008-11-14
First Post:
2005-08-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)
Sponsor:
Japan Adult Leukemia Study Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-09
Start Date Type:
None
Primary Completion Date:
2008-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-12
First Submit QC Date:
None
Study First Post Date:
2005-08-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-11-13
Last Update Post Date:
2008-11-14
Last Update Post Date Type:
ESTIMATED